Search company, investor...

Predict your next investment

Venture Capital
INDUSTRIALS | Basic Materials
esplp.com

Investments

67

Portfolio Exits

5

Funds

2

About Early Stage Partners

ESP Early Stage Partners was formed in 2001 with the intent to invest in Midwest technology companies that would be attractive early stage venture capital investment opportunities. The firm currently has $98 million in capital under management. In 2009, Early Stage Partners opened a Michigan office in Ann Arbor. Early Stage Partners is a member of the Ohio Venture Association and the Michigan Venture Capital Association.

Headquarters Location

1801 E. 9th Street Suite 1700

Cleveland, Ohio, 44114,

United States

216-781-4600

Are you an investor?
Submit your portfolio details now to be considered in our investor rankings.

Latest Early Stage Partners News

genesis raises USD1.8m from Illuminate Financial Management and Tribeca Early Stage Partners

Dec 23, 2019

Submitted 23/12/2019 - 10:40am genesis, an international capital markets software firm has held the closing of its second capital raise, securing USD1.8 million of investment in a round that was led by Illuminate Financial Management, a UK-based capital markets venture capital firm and Tribeca Early Stage Partners, a New York venture group. genesis has now raised USD5 million since its first external capital injection in November 2018. The new funding will be invested in further development of genesis platform’s core technology, sales and marketing to cement genesis’ position as the ‘low-code’ platform for capital markets software development. Across the entire capital markets industry, firms are under continuous pressure to digitise manual and repetitive business processes, as well as address a swathe of industry challenges. These range from meeting wide-reaching regulatory requirements, to the limitations of incumbent vendors and software methodology processes, all while finding ways to increase revenue and reduce operational cost. The genesis platform is a Low-Code Application Platform, built specifically for capital markets, that enables the rapid creation of products and solutions without having to write substantial lines of code. Infrastructure management is minimised and the genesis platform ultimately democratises product design as the coding required is radically reduced, making the development of solutions much faster and much simpler. A unique proposition for the financial services industry, genesis Low-Code Application Platform is the only platform capable of supporting the requirements of capital markets, by building solutions that are highly resilient, scalable and performant. A growing suite of products to serve a wide range of functional areas have already been built, implemented and deployed on genesis’ Low-Code Application Platform— ranging from a new interest rate pricing product, to a credit risk insurance syndicate loan marketplace through to wealth management portfolio structuring and workflow products. Commenting on the funding, Mark Beeston, Managing Partner and Founder of Illuminate Financial Management, says: “Since Illuminate invested in late 2018 genesis has really emerged as the leading provider in the low-code, pro-code movement within capital markets. We see genesis as the industry key to enabling digitisation and the innovation it supports. We are pleased to further support their journey.” Tribeca Early Stage Partners, a US network of entrepreneurs and business leaders with deep domain expertise in institutional finance and enterprise technology joined the investment round. Nick Ogurtsov, Partner at Tribeca Early Stage Partners, adds: “From the first time we met genesis, we felt the real potential to fundamentally re-define the very standards of software development within capital markets. This is exactly what we see genesis doing today, with its low-code platform that creates dramatically faster time-to-market at a much lower cost than traditional software development methods." “We are delighted by the continued investment and support of Illuminate Financial and Tribeca Early Stage Partners. Their investment puts us in a really strong position to continue to grow and lead a critical effort to make low-code application development prevalent across capital markets.” says Stephen Murphy, CEO of genesis. “Low-code has been used widely outside the industry to create applications at speed, and at a drastically reduced cost, although to date these platforms have not been built to support capital markets. We are excited by what we have already achieved both in creating new solutions and products, improving existing solutions and now look forward to bringing genesis Low-Code Application Platform to the capital markets community en masse.” Author Profile

Early Stage Partners Investments

67 Investments

Early Stage Partners has made 67 investments. Their latest investment was in Family Care Path as part of their Series A on July 7, 2019.

CBI Logo

Early Stage Partners Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

7/26/2019

Series A

Family Care Path

$0.8M

Yes

2

9/21/2017

Unattributed VC - III

Pixel Velocity

$4.34M

Yes

3

2/8/2017

Series B

HistoSonics

$8.26M

No

2

4/13/2016

Series D

Subscribe to see more

$99M

Subscribe to see more

10

9/3/2015

Series D

Subscribe to see more

$99M

Subscribe to see more

10

Date

7/26/2019

9/21/2017

2/8/2017

4/13/2016

9/3/2015

Round

Series A

Unattributed VC - III

Series B

Series D

Series D

Company

Family Care Path

Pixel Velocity

HistoSonics

Subscribe to see more

Subscribe to see more

Amount

$0.8M

$4.34M

$8.26M

$99M

$99M

New?

Yes

Yes

No

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

2

3

2

10

10

Early Stage Partners Portfolio Exits

5 Portfolio Exits

Early Stage Partners has 5 portfolio exits. Their latest portfolio exit was Amplifinity on August 20, 2019.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

8/20/2019

Acquired

$99M

1

8/30/2014

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

8/22/2014

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

7/31/2014

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

5/9/2006

Acq - Fin

Subscribe to see more

$99M

Subscribe to see more

0

Date

8/20/2019

8/30/2014

8/22/2014

7/31/2014

5/9/2006

Exit

Acquired

Acquired

Acquired

Acquired

Acq - Fin

Companies

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

$99M

Acquirer

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

1

10

10

10

0

Early Stage Partners Fund History

2 Fund Histories

Early Stage Partners has 2 funds, including Early Stage Partners II LP.

Closing Date

Fund

Fund Type

Status

Amount

Sources

5/11/2010

Early Stage Partners II LP

Early-Stage Venture Capital

Closed

$55M

1

9/13/2002

Early Stage Partners I LP

Subscribe to see more

Subscribe to see more

$99M

10

Closing Date

5/11/2010

9/13/2002

Fund

Early Stage Partners II LP

Early Stage Partners I LP

Fund Type

Early-Stage Venture Capital

Subscribe to see more

Status

Closed

Subscribe to see more

Amount

$55M

$99M

Sources

1

10

Early Stage Partners Team

4 Team Members

Early Stage Partners has 4 team members, including current Managing Director, Michael Bunker.

Name

Work History

Title

Status

Michael Bunker

Arboretum Ventures, C.R. Bard, and Medtronic

Managing Director

Current

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Name

Michael Bunker

Subscribe to see more

Subscribe to see more

Subscribe to see more

Work History

Arboretum Ventures, C.R. Bard, and Medtronic

Title

Managing Director

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Current

Subscribe to see more

Subscribe to see more

Subscribe to see more

Compare Early Stage Partners to Competitors

Kleiner Perkins Caufield & Byers Logo
Kleiner Perkins Caufield & Byers

Kleiner Perkins Caufield & Byers (KPCB) is a venture capital firm based in Menlo Park, CA that primarily focuses its global investments in practice areas including technology and life sciences.

Pioneer Square Labs Logo
Pioneer Square Labs

Pioneer Square Labs is a venture studio that creates its startups. It engages its venture capital and angel investor base to provide initial funding for these spin-outs. The company was founded in 2015 and is based in Seattle, Washington.

Sequoia Capital Logo
Sequoia Capital

Sequoia is a venture capital firm. It seeks to invest in companies operating in the information technology, healthcare, manufacturing, mobile, nanotechnology, financial service, internet, energy, media, and retail sectors. The company was founded in 1972 and is based in Menlo Park, California.

Vation Ventures Logo
Vation Ventures

Vation Ventures operates a research platform that allows customers to understand landscapes, investment trends, offerings, and company information. Its platform provides early-stage companies with the support needed to quickly accelerate their growth. The firm was founded in 2021 and is based in Denver, Colorado.

C
Catalyst

Catalyst is a search and social digital marketing agency, specialized in developing digital solutions. It is based in Boston, Massachusetts.

A
Accelerain

Accelerain is a sales development firm. It provides meeting scheduling, sales recruiting, sales development training, consulting, and other services to grow revenue. It serves the information technology, consulting, telecommunications, biotech, healthcare, marketing, and other sectors. It was founded in 2014 and is based in Philadelphia, Pennsylvania.

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.